Therapeutic antibodies for autoimmunity and inflammation

被引：666
作者：
Chan, Andrew C. [1 ]
Carter, Paul J. [2 ]
机构：
[1] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA
来源：
NATURE REVIEWS IMMUNOLOGY | 2010年 / 10卷 / 05期
关键词：
INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; CHRONIC IDIOPATHIC URTICARIA; ANTITUMOR NECROSIS FACTOR; NEONATAL FC-RECEPTOR; B-CELL DEPLETION; COLLAGEN-INDUCED ARTHRITIS; GROWTH-FACTOR RECEPTOR; EPSILON-RI EXPRESSION; HUMAN IGG1; RHEUMATOID-ARTHRITIS;
D O I：
10.1038/nri2761
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The development of therapeutic antibodies has evolved over the past decade into a mainstay of therapeutic options for patients with autoimmune and inflammatory diseases. Substantial advances in understanding the biology of human diseases have been made and tremendous benefit to patients has been gained with the first generation of therapeutic antibodies. The lessons learnt from these antibodies have provided the foundation for the discovery and development of future therapeutic antibodies. Here we review how key insights obtained from the development of therapeutic antibodies complemented by newer antibody engineering technologies are delivering a second generation of therapeutic antibodies with promise for greater clinical efficacy and safety.
引用
收藏
页码：301 / 316
页数：16
相关论文
共 164 条
  • [1] ALEGRE ML, 1994, TRANSPLANTATION, V57, P1537
  • [2] Humanization of antibodies
    Almagro, Juan C.
    Fransson, Johan
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 1619 - 1633
  • [3] The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus
    Anolik, JH
    Campbell, D
    Felgar, RE
    Young, F
    Sanz, I
    Rosenblatt, J
    Looney, RJ
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 455 - 459
  • [4] IL-1, IL-18, and IL-33 families of cytokines
    Arend, William P.
    Palmer, Gaby
    Gabay, Cem
    [J]. IMMUNOLOGICAL REVIEWS, 2008, 223 : 20 - 38
  • [5] Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
    Baert, F
    Noman, M
    Vermeire, S
    Van Assche, G
    D'Haens, G
    Carbonez, A
    Rutgeerts, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) : 601 - 608
  • [6] Bispecific T-Cell Engaging Antibodies for Cancer Therapy
    Baeuerle, Patrick A.
    Reinhardt, Carsten
    [J]. CANCER RESEARCH, 2009, 69 (12) : 4941 - 4944
  • [7] Tumor regression in cancer patients by very low doses of a T cell-engaging antibody
    Bargou, Ralf
    Leo, Eugen
    Zugmaier, Gerhard
    Klinger, Matthias
    Goebeler, Mariele
    Knop, Stefan
    Noppeney, Richard
    Viardot, Andreas
    Hess, Georg
    Schuler, Martin
    Einsele, Hermann
    Brandl, Christian
    Wolf, Andreas
    Kirchinger, Petra
    Klappers, Petra
    Schmidt, Margit
    Riethmueller, Gert
    Reinhardt, Carsten
    Baeuerle, Patrick A.
    Kufer, Peter
    [J]. SCIENCE, 2008, 321 (5891) : 974 - 977
  • [8] Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
    Bartelds, Geertje M.
    Wijbrandts, Carla A.
    Nurmohamed, Michael T.
    Stapel, Steven
    Lems, Willem F.
    Aarden, Lucien
    Dijkmans, Ben A. C.
    Tak, Paul Peter
    Wolbink, Gerrit Jan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) : 921 - 926
  • [9] Omalizumab-induced reductions in mast cell FcεRI expression and function
    Beck, LA
    Marcotte, GV
    MacGlashan, D
    Togias, A
    Saini, S
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) : 527 - 530
  • [10] Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation
    Beers, Stephen A.
    Chan, Claude H. T.
    James, Sonya
    French, Ruth R.
    Attfield, Kathrine E.
    Brennan, Claire M.
    Ahuja, Anupama
    Shlomchik, Mark J.
    Cragg, Mark S.
    Glennie, Martin J.
    [J]. BLOOD, 2008, 112 (10) : 4170 - 4177
12345678910